-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US71902K1135 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Dividend Yield | None |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.73 |
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CEROW using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025